Using Evidence-Based Medicine to Drive Evidence-Based Practice
CLUE® is a Population Health Management tool developed by Arche Healthcare for health plans committed to improving outcomes of their patients with diabetes. Arche’s Healthcare’s CLUE strategy offers healthcare providers, health plans and other healthcare stakeholders a seamless and compliant healthcare delivery strategy that will:
- Standardize the individualized risk stratification profile
- Document patient findings and measure outcomes
- Provide appropriately sized therapeutic footwear and insoles
- Procure the required DME documentation for reimbursement
- Achieve the required level of healthcare literacy to participate in a personalized care strategy
- Meet the new standards of care that are so heavily dependent on quality measures
In a strategic alliance with health plans, Arche Healthcare’s CLUE program provides an engaging and cost-effective healthcare delivery service to prevent wounds and amputations.
Created by the team of world renowned clinicians and diabetic researchers, Arche Healthcare’s CLUE program is evidence-based and our advanced IT platforms, diagnostic devices , insightful analytics and unparalleled patient experience create a transformational approach to diabetic foot care.
Arche Healthcare’s CLUE program helps forward-thinking health plans achieve a compelling ROI given the significant costs associated with complications such as wounds and amputations.
All estimates and calculations always assume medical necessity and normal Standard of Care.
Ref. # Citation
- CMS. Chronic Conditions among Medicare Beneficiaries, Chartbook, 2012 Edition. Baltimore, MD, 2012. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/Downloads/2012Chartbook.pdf
- Peters EJG and Lavery LA Effectiveness of the Diabetic Foot Risk Classification System of the International Working Group on the Diabetic Foot. Diabetes Care 2001;24(8):1442-1447.
- Margolis DJ, Malay DS, Hoffstad OJ, et al. Incidence of Diabetic Foot Ulcer and Lower Extremity Amputation Among Medicare Beneficiaries, 2006 to 2008: Data Points #2. Data Points Publication Series. Rockville, MD 2011.
- Rice JB, Cummings AKG, Birnbaum HG, Skornicki M, Parsons NB. Burden of Diabetic Foot Ulcers for Medicare and Private Insurers. Diabetes Care 2014;37:651-658.
- Carls GS, Gibson TB, Driver VR, et al. The Economic Value of Specialized Lower-Extremity Medical Care by Podiatric Physicians in the Treatment of Diabetic Foot Ulcers. J Am Podiatr Med Assoc. 2011;101(2):91-115.
- Rith-Najarian S, Branchaud C, Beaulieu O, Gohdes D, Simonson G, Mazze R. Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. J Fam Pract 1998;47:127-32.
- Dargis V, Pantelejeva O, Jonushaite A, Vileikyte L, Boulton AJ. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 1999;22:1428-31.
- Lavery LA, Wunderlich RP, Tredwell JL. Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes Res Clin Pract 2005;70:31-7.